Cerenome (PSTV) Exchange Rate Effect (2013 - 2019)
Plus Therapeutics (PSTV) posted quarterly Exchange Rate Effect of -$4000.0 for Q1 2019, down 110.26% year-over-year from $39000.0 in Q1 2018, and down 115.38% quarter-over-quarter from $26000.0 in Q4 2018.
Cerenome (PSTV) Exchange Rate Effect (2013 - 2019) Analysis & Trends
Plus Therapeutics (PSTV) has reported Exchange Rate Effect for 7 consecutive years, with -$4000.0 the latest figure, recorded in Q1 2019.
- In Q1 2019, Exchange Rate Effect fell 110.26% year-over-year to -$4000.0; the TTM figure through Dec 2019 stood at -$4000.0 (down 125.0% YoY), while the FY2019 annual figure was -$4000.0, down 125.0% from the prior year.
- Exchange Rate Effect retreated to -$4000.0 in Q1 2019 per PSTV's latest filing, from $26000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $85000.0 in Q1 2016 and bottomed at -$58000.0 in Q4 2016.
- Historically, Exchange Rate Effect has averaged $7000.0 across 5 years, with a median of $1000.0 in 2016.
- Annual changes were most pronounced in 2015 — Exchange Rate Effect tumbled 3000.0% — and 2016, when it jumped 466.67%.
- Plus Therapeutics' Exchange Rate Effect stood at $14000.0 in 2015, then plunged by 514.29% to -$58000.0 in 2016, then jumped by 96.55% to -$2000.0 in 2017, then surged by 1400.0% to $26000.0 in 2018, then tumbled by 115.38% to -$4000.0 in 2019.
- Business Quant data shows PSTV's Exchange Rate Effect at -$4000.0 in Q1 2019, $26000.0 in Q4 2018, and -$22000.0 in Q3 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.09 Bn | 131.23 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.66 Bn | 77.66 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.86 Bn | 59.67 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.07 Bn | 52.93 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.87 Bn | 36.77 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.45 Bn | 28.15 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 27.90 Bn | 9.51 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - | - |
| 10 | Cerenome | 28.07 Mn | 19.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | -4,000.00 |
| Mar 31, 2019 | -4,000.00 |
| Dec 31, 2018 | 26,000.00 |
| Dec 31, 2018 | 26,000.00 |
| Sep 30, 2018 | -22,000.00 |
| Sep 30, 2018 | -22,000.00 |
| Jun 30, 2018 | -27,000.00 |
| Jun 30, 2018 | -27,000.00 |
| Mar 31, 2018 | 39,000.00 |
| Mar 31, 2018 | 39,000.00 |
| Sep 30, 2017 | -2,000.00 |
| Sep 30, 2017 | -2,000.00 |
| Jun 30, 2017 | -7,000.00 |
| Jun 30, 2017 | -7,000.00 |
| Mar 31, 2017 | 20,000.00 |
| Mar 31, 2017 | 20,000.00 |
| Dec 31, 2016 | -58,000.00 |
| Dec 31, 2016 | -58,000.00 |
| Sep 30, 2016 | 1,000.00 |
| Sep 30, 2016 | 1,000.00 |